Innovative Solutions for Software Challenges (Soluciones Innovadoras para Desafíos de Software)
Funds software firms and public researchers in applied innovation partnerships for health and energy.
Soluciones Innovadoras is a competitive applied-R&D instrument co-administered by Fundación Sadosky and Argentina's Ministerio de Ciencia, Tecnología e Innovación. Launched in 2022, the programme pairs Argentine software and IT services companies with research groups from the national science system (SNCyT) to develop collaborative projects in five strategic sectors: health, satellite industry, bi…
Applied software R&D projects pairing Argentine IT companies with public research groups in strategic sectors: health, satellite industry, bioeconomy, and energy transition.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see what winners did
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Write proposalGrant Proposal Example: Sample Applications and What to Learn From Them
Learn how to use grant proposal examples, sample applications, and public funded proposals without copying weak structure or missing funder-specific rules.
More from Fundacion Sadosky
All grants from this funder →Similar grants
Browse the directory →
SIP Phase 3 — Active Consortia Participation
🇯🇵CSTI Japan · Japan
Funds cross-ministerial Japanese innovation across energy, health, and robotics to strengthen real-world implementation.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
ASPIRE Reduction-to-Practice (Seed)
🇺🇸NCATS · United States
Supports translational chemistry and automation platform development through university-linked partnerships.
DARPA SBIR Phase I
🇺🇸DARPA · United States
Funds United States small businesses validating high-risk defense science concepts for practical technical development.
DARPA SBIR Phase II
🇺🇸DARPA · United States
Supports United States defense innovators building on validated concepts into advanced prototypes and field testing.